Home › Funds › STEMPOINT CAPITAL LP › TYRA
STEMPOINT CAPITAL LP position in TYRA
TYRA BIOSCIENCES INC COM · Health Care
STEMPOINT CAPITAL LP reported holding 632,754 shares of TYRA (TYRA BIOSCIENCES INC COM) in its Q2 2026 13F filing — a position valued at US$20.2M, representing 4.47% of its reported portfolio and ranking #2 among its reported holdings. STEMPOINT CAPITAL LP has disclosed TYRA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How STEMPOINT CAPITAL LP's TYRA position evolved
STEMPOINT CAPITAL LP first disclosed a stake in TYRA in Q1 2026 at 100,000 shares (US$290K). The position peaked in Q2 2026 at 632,754 shares, worth US$20.2M. Across 2 filings, STEMPOINT CAPITAL LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 632,754 shares valued at US$20.2M — an increase of 532,754 shares quarter over quarter.. Notable position changes include a 533% increase in Q2 2026 (shares fell 32% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 100.00K | $290.00K | New |
| Q2 2026 | 632.75K | $20.21M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TYRA and 13F data
TYRA (TYRA BIOSCIENCES INC COM) is a Health Care company. 57 other funds we track also report a position in TYRA — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$389.6M), Alta Partners Management Company, L.P. (US$122.1M), Nextech Invest Ltd. (US$113.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TYRA
- RA CAPITAL MANAGEMENT, L.P. 12.20M sh · $389.62M · Q2 2026
- Alta Partners Management Company, L.P. 3.82M sh · $122.12M · Q2 2026
- Nextech Invest Ltd. 3.55M sh · $113.50M · Q2 2026
- TCG Crossover Management, LLC 3.25M sh · $103.77M · Q2 2026
- Commodore Capital LP 1.88M sh · $59.89M · Q2 2026
- Paradigm Biocapital Advisors LP 1.83M sh · $58.41M · Q2 2026
- BVF INC/IL 1.48M sh · $47.15M · Q2 2026
- 5AM Venture Management, LLC 1.03M sh · $32.88M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.02M sh · $32.48M · Q2 2026
- Caligan Partners LP 806.99K sh · $25.78M · Q2 2026
- Canaan Partners XI LLC 750.00K sh · $23.95M · Q2 2026
- Sio Capital Management, LLC 695.32K sh · $22.21M · Q2 2026
More on STEMPOINT CAPITAL LP
FAQ
How long has STEMPOINT CAPITAL LP held TYRA?
STEMPOINT CAPITAL LP has disclosed TYRA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is STEMPOINT CAPITAL LP's current position in TYRA?
As of Q2 2026, STEMPOINT CAPITAL LP holds 632.75K shares of TYRA (TYRA BIOSCIENCES INC COM), valued at $20.21M, representing 4.47% of its reported portfolio and ranking #2.
Has STEMPOINT CAPITAL LP been buying or selling TYRA?
In the latest 13F filing (Q2 2026), STEMPOINT CAPITAL LP increased its position in TYRA. The position peaked in Q2 2026 at 632.75K shares.
Which other funds hold TYRA?
Other major institutional holders of TYRA include RA CAPITAL MANAGEMENT, L.P., Alta Partners Management Company, L.P., Nextech Invest Ltd., among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.